Great Point Partners’s Akero Therapeutics AKRO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$5.54M	Buy	+103,848	New	+$5.54M	3.6%	11
2023 Q4	–	Sell	-198,500	Closed	-$10M	–	37
2023 Q3	$10M	Buy	+198,500	New	+$10M	1.83%	25